Imaging the Urokinase Plasminongen Activator Receptor in Preclinical Breast Cancer Models of Acquired Drug Resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imaging the Urokinase Plasminongen Activator Receptor in Preclinical Breast Cancer Models of Acquired Drug Resistance

Published:2014 Issue:3 Volume:4 Page:267-279
ISSN:1838-7640
Container-title:Theranostics
language:en
Short-container-title:Theranostics

Author:

LeBeau Aaron M.,Sevillano Natalia,King Mandy L.,Duriseti Sai,Murphy Stephanie T.,Craik Charles S.,Murphy Laura L.,VanBrocklin Henry F.

Publisher

Ivyspring International Publisher

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Medicine (miscellaneous)

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haemostatic Proteins as Markers of Disease Progression and Prognosis in Breast Cancer;2024-07-12

2. Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer;Progress in Materials Science;2023-04

3. High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions;mAbs;2023-03

4. Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer;Journal of Translational Medicine;2022-03-18

5. Clinical aspect of cancer and fibrinolysis;Japanese Journal of Thrombosis and Hemostasis;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP